Stapokibart shows promise in reducing nasal congestion in seasonal allergy patients, study finds Post author: Post published:February 9, 2024 Post category:uncategorized The efficacy and safety of stapokibart as an in patients with seasonal allergic rhinitis (SAR). You Might Also Like Advancements in neoantigen vaccines offer hope for personalized cancer therapy August 19, 2024 Poor dietary habits in adolescence associated with social media overuse April 7, 2025 Why You Need to Address Diabetes Distress December 22, 2023